Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MITO | AMGN | GILD | VRTX | BIIB |
| Company | Stealth Biotherapeutics Corp ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3200 | 335.15 | 83.26 | 474.36 | 200.01 |
| High | 0.3300 | 335.73 | 83.61 | 474.61 | 200.37 |
| Low | 0.3200 | 334.27 | 82.76 | 473.17 | 196.97 |
| Last | 0.3200 | 336.27 | 83.37 | 474.00 | 199.16 |
| Change | -0.0044 | +0.32 | -0.53 | -3.90 | -2.28 |
| % Change | -1.36% | +0.10% | -0.63% | -0.82% | -1.13% |
| Volume | 1,299,700 | 802,952 | 1,728,642 | 265,607 | 201,378 |
| 20-Day Average Volume | 326,330 | 1,656,529 | 6,406,946 | 931,895 | 789,792 |
| Previous Close | 0.3244 | 335.95 | 83.90 | 477.90 | 201.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3198 | 330.12 | 80.44 | 479.53 | 201.33 |
| 20-Day Raw Stochastic | 43.50% | 80.63% | 81.07% | 31.58% | 39.86% |
| 20-Day Relative Strength | 54.62% | 56.80% | 68.32% | 46.95% | 41.56% |
| Weighted Alpha | -24.32 | +26.66 | +16.86 | +31.70 | -23.45 |
| Today's Opinion | 40% Buy | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 8% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 11/08/22 | +0.80% since 09/13/24 | +0.46% since 09/13/24 | -2.51% since 09/13/24 | +1.22% since 09/13/24 |
| Low | 0.3200 on 11/15/22 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 473.18 on 09/20/24 | 194.75 on 09/16/24 |
| High | 0.3300 on 11/15/22 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | +1.59% since 10/14/22 | +2.00% since 08/20/24 | +11.29% since 08/20/24 | -2.91% since 08/20/24 | -3.64% since 08/20/24 |
| Low | 0.3100 on 10/17/22 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 0.3300 on 11/15/22 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +2.89% since 08/15/22 | +8.14% since 06/20/24 | +21.46% since 06/20/24 | +0.38% since 06/20/24 | -12.22% since 06/20/24 |
| Low | 0.2911 on 08/16/22 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 0.3300 on 11/15/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +41.72% since 05/13/22 | +22.73% since 03/20/24 | +12.45% since 03/20/24 | +14.82% since 03/20/24 | -9.23% since 03/20/24 |
| Low | 0.1621 on 05/25/22 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.4270 on 06/08/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,537 | 180,215,344 | 104,527,072 | 123,323,528 | 29,329,060 |
| Shares Outstanding, K | 73,552 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -52,530,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -8,136,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 1.46 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 05/18/22 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/17/22 | 10/29/24 | 11/05/24 | 11/04/24 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 0.00 | 12.15 |